why tendons were tested / what happened
What Did BPC-157 Do in Tendon and Ligament Studies?
Researchers hoped the compound might help badly hurt tissue mend. A fully cut rat Achilles tendon improved by each test used. The human knee report proves much less.
What happened to the fully cut Achilles tendon?
Researchers asked whether BPC-157 could help a badly hurt tendon mend. They cut each rat's Achilles tendon through. Each rat got 10 micrograms, 10 nanograms, or 10 picograms once a day. Treated tendons grew stronger, worked better, and rebuilt in better order [1]. Tendon cells taken from the rats also spread farther [1].
Strength is the best result here. A tendon that bears more load is doing its job better. Treated rats also used the hurt leg more. Under a microscope, their collagen lay in straighter lines. The cut ends looked better joined. Several tests agreed, which gives the rat finding more weight.
The amount range was striking too. Results appeared from 10 micrograms down to 10 picograms. The largest amount was a million times the smallest. Other teams need to repeat such a wide result. BPC-157 may have helped those rats. It can't promise the same healing for you.
How might the tendon have healed?
BPC-157 may help new blood vessels reach hurt tissue. Tests with cells found more of a switch that starts vessel growth [3]. Tendons get little blood, which is one reason they heal slowly. Other tests found that tendon cells spread and multiplied. The cells also made more docking spots for growth hormone [1]. Researchers don't know whether that last change helps or harms people.
Fresh blood may then reach a healing tendon. Its cells can move into the cut area. In the rat Achilles test, BPC-157 changed tangled scar collagen into straighter fibers that bore weight. Researchers saw those links in animals and cells removed from tendon. That work can't show what your tendon would do. Read more about how BPC-157 may work.
What about ligaments and tendon joined to bone?
Sales pages call BPC-157 a "tendon and ligament" peptide. The best test, though, is the fully cut rat Achilles tendon. Claims about ligaments, tendon joined to bone, and muscle come from a wider set of animal studies. A 2025 review called the question "Regeneration or Risk?" [8]. It found broad animal support, but human evidence stops at three early reports and no large fair trials [8].
Animal work also found quicker repair after a muscle was crushed [11]. That means mending an injury, not adding muscle to an unhurt person. For ligaments and tendon joined to bone, the strongest work still comes from animals. Many first papers came from one team, so fresh researchers need to repeat them [8]. BPC-157 has a real rat-tendon finding. The claims around that finding are far less sure.
What did the small knee report find in people?
The closest human report gave BPC-157 shots into sore knees. Pain of several types eased after the shots [6]. But the report was small. It lacked a comparison group using another treatment or a placebo. Pain can ease on its own, and hope can change how pain feels. Without that fair match, the cause stays unknown.
This was one of only three reports in people. The others were a 2024 bladder study [9] and a 2025 vein-safety study [7]. A 2025 review said the human work was too small for a sound medical verdict [8]. The knee report is worth reading because sales pages lean on it. It still isn't proof that the compound treats knee pain.
Has BPC-157 healed arthritis in a fair trial?
BPC-157 has not had a fair arthritis trial in people. One small report found less pain after shots into sore knees [6]. It lacked a group getting other care or a placebo. The cause could be the compound, time, or hope.
When did BPC-157 have an effect in studies?
Animal studies watched tendon repair across days or weeks; nothing happened at once. The rat Achilles work gave a dose each day [1]. In people, no trusted start time exists. The few reports lacked fair comparison groups [8].